D

Teleflex Incorporated TFX

$130.99 -$1.01-0.77% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Teleflex Incorporated is a U.S.-based medical technology company that develops, manufactures, and supplies specialty medical devices used by hospitals and healthcare providers worldwide. The company operates primarily in the medical devices and healthcare equipment industries, with a focus on critical care, surgical, cardiovascular, urology, interventional, and respiratory applications. Its products are used in acute care and surgical settings, including intensive care units, emergency departments, operating rooms, and catheterization labs. Revenue is primarily generated through the sale of single-use medical devices and procedural technologies to hospitals, ambulatory surgery centers, and healthcare distributors.

The company’s principal business lines include vascular access products, interventional cardiology and radiology devices, anesthesia and respiratory care technologies, surgical instruments, and urology products. Teleflex has developed strong market positions in catheter-based technologies and minimally invasive procedural solutions through both internal product development and acquisitions. Historically, the company originated as a diversified industrial manufacturer before shifting its strategic focus toward medical technologies during the 2000s and 2010s. Multiple divestitures of non-medical businesses and acquisitions of specialized device companies transformed Teleflex into a predominantly healthcare-focused enterprise.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
610-225-6800
Address
550 East Swedesford Road
Suite 400
Wayne, PA 19087-1603
Country
Year Founded

Headlines

9/11/2026 - Zacks Investment Research
8/28/2026 - Zacks Investment Research
8/28/2026 - Zacks Investment Research
8/26/2026 - Zacks Investment Research